Bert Vogelstein | |
|---|---|
 | |
| Born | June 2, 1949 Baltimore, Maryland, U.S. |
| Alma mater | University of Pennsylvania Johns Hopkins School of Medicine |
| Known for | p53, Vogelgram, somatic evolution in cancer |
| Spouse | Ilene Vogelstein |
| Children | R. Jacob Vogelstein, Joshua T. Vogelstein, and one more, Grandchildren: 5 |
| Awards | Breakthrough Prize in Life Sciences (2013)[1] Warren Triennial Prize (2014)[2] |
| Scientific career | |
| Fields | Oncology, Pathology |
| Institutions | Johns Hopkins School of Medicine |
| Doctoral students | |
| Website | www |
Bert Vogelstein (born 1949) is director of the Ludwig Center, Clayton Professor of Oncology and Pathology and a Howard Hughes Medical Institute investigator at The Johns Hopkins Medical School and Sidney Kimmel Comprehensive Cancer Center.[4] A pioneer in the field of cancer genomics, his studies on colorectal cancers revealed that they result from the sequential accumulation of mutations in oncogenes and tumor suppressor genes. These studies now form the paradigm for modern cancer research and provided the basis for the notion of the somatic evolution of cancer.
- ^ "Breakthrough Prize – Life Sciences Breakthrough Prize Laureates – Bert Vogelstein". breakthroughprize.org.
- ^ "Mass. General Hospital's Warren Triennial Prize to honor Bert Vogelstein, MD - Massachusetts General Hospital, Boston, MA". Archived from the original on 2015-02-21. Retrieved 2015-02-21.
- ^ Landau, Misia (1 January 2015). "An Interview with Bert Vogelstein and Kenneth Kinzler". Clinical Chemistry. 61 (1): 9–20. doi:10.1373/clinchem.2014.223271. PMID 25550474 – via clinchem.aaccjnls.org.
- ^ "Interview with Bert Vogelstein". Archived from the original on 2013-06-03. Retrieved 2010-04-30.